Literature DB >> 23794069

Herpes simplex virus type 2 cross-sectional seroprevalence and the estimated rate of neonatal infections among a cohort of rural Malawian female adolescents.

Christopher R Sudfeld1, Paul C Hewett, Nadia N Abuelezam, Satvika Chalasani, Erica Soler-Hampejsek, Christine A Kelly, Barbara S Mensch.   

Abstract

OBJECTIVE: To assess herpes simplex virus type 2 (HSV-2) seroprevalence among rural Malawian adolescent women and estimate the number of neonatal herpes infections among infants of these adolescents.
METHODS: A longitudinal cohort study of adolescents (14-16 years at entry) residing in rural Malawi was initiated in 2007 with annual observation. HSV-2 testing was introduced in 2010. In this study, we (1) determined, using cross-sectional analysis, risk factors for positive serostatus, (2) adjusted for non-response bias with imputation methods and (3) estimated the incidence of neonatal herpes infection using mathematical models.
RESULTS: A total of 1195 female adolescents (age 17-20 years) were interviewed in 2010, with an observed HSV-2 seroprevalence of 15.2% among the 955 women tested. From a multivariate analysis, risk factors for HSV-2 seropositivity include older age (p=0.037), moving from the baseline village (p=0.020) and report of sexual activity with increasing number of partners (p<0.021). Adjusting for non-response bias, the estimated HSV-2 seroprevalence among the total female cohort (composed of all women interviewed in 2007) was 18.0% (95% CI 16.0% to 20.2%). HSV-2 seropositivity was estimated to be 25.6% (95% CI 19.6% to 32.5%) for women who refused to provide a blood sample. The estimated number of neonatal herpes infections among the total female cohort was 71.8 (95% CI 57.3 to 86.3) per 100 000 live births.
CONCLUSIONS: The risk of HSV-2 seroconversion is high during adolescence, when childbearing is beginning, among rural Malawian women. Research on interventions to reduce horizontal and vertical HSV-2 transmission during adolescence in resource-limited settings is needed.

Entities:  

Keywords:  Adolescent; Epidemiology (Clinical); Herpes Simplex (Clinical); Modeling; Neonates

Mesh:

Substances:

Year:  2013        PMID: 23794069      PMCID: PMC3923533          DOI: 10.1136/sextrans-2012-050869

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  24 in total

1.  ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-06       Impact factor: 7.661

2.  HIV testing in national population-based surveys: experience from the Demographic and Health Surveys.

Authors:  Vinod Mishra; Martin Vaessen; J Ties Boerma; Fred Arnold; Ann Way; Bernard Barrere; Anne Cross; Rathavuth Hong; Jasbir Sangha
Journal:  Bull World Health Organ       Date:  2006-07       Impact factor: 9.408

3.  Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania.

Authors:  Mabula Joseph Kasubi; Arvid Nilsen; Howard S Marsden; Tomas Bergström; Nina Langeland; Lars Haarr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Binomial regression in GLIM: estimating risk ratios and risk differences.

Authors:  S Wacholder
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

Review 5.  Herpes simplex virus infections in neonates and early childhood.

Authors:  David W Kimberlin
Journal:  Semin Pediatr Infect Dis       Date:  2005-10

6.  A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection.

Authors:  P Brocklehurst; G Kinghorn; O Carney; K Helsen; E Ross; E Ellis; R Shen; F Cowan; A Mindel
Journal:  Br J Obstet Gynaecol       Date:  1998-03

7.  The acquisition of herpes simplex virus during pregnancy.

Authors:  Z A Brown; S Selke; J Zeh; J Kopelman; A Maslow; R L Ashley; D H Watts; S Berry; M Herd; L Corey
Journal:  N Engl J Med       Date:  1997-08-21       Impact factor: 91.245

Review 8.  Genital herpes.

Authors:  Rachna Gupta; Terri Warren; Anna Wald
Journal:  Lancet       Date:  2007-12-22       Impact factor: 79.321

Review 9.  Epidemiology of herpes simplex virus type 2 infection in the developing world.

Authors:  Helen Weiss
Journal:  Herpes       Date:  2004-04

10.  Mobility and HIV in Tanzanian couples: both mobile persons and their partners show increased risk.

Authors:  Coleman Kishamawe; Debby C J Vissers; Mark Urassa; Raphael Isingo; Gabriel Mwaluko; Gerard J J M Borsboom; Hélène A C M Voeten; Basia Zaba; J Dik F Habbema; Sake J de Vlas
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

View more
  4 in total

1.  Evaluation of Herpes Simplex Virus Type 2 Serological Tests for Use With Dried Blood Spots in Kenya.

Authors:  Marcia M Hobbs; Sophie W Mwanyumba; Winnie K Luseno; Shane Hartman; Carolyn T Halpern; Denise D Hallfors; Hyunsan Cho
Journal:  Sex Transm Dis       Date:  2017-02       Impact factor: 2.830

2.  An Assessment of Risk Factors for Herpes Simplex Virus Type 2 Infection in Malawian Women Using 2 Classifications for the HerpeSelect 2 Test.

Authors:  Payal Chakraborty; Alison H Norris; Sarah Huber-Krum; Sarah Garver; Robert B Hood; Venson Banda; Allahna Esber; Carr Reese Patricia; Robert Krysiak; Abigail Norris Turner
Journal:  Sex Transm Dis       Date:  2020-03       Impact factor: 3.868

3.  Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.

Authors:  William P Halford; Joshua Geltz; Ronald J Messer; Kim J Hasenkrug
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

4.  Herpes simplex virus: global infection prevalence and incidence estimates, 2016.

Authors:  Charlotte James; Manale Harfouche; Nicky J Welton; Katherine Me Turner; Laith J Abu-Raddad; Sami L Gottlieb; Katharine J Looker
Journal:  Bull World Health Organ       Date:  2020-03-25       Impact factor: 9.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.